With the UK seeing a major shift in how we approach clinical weight management, two treatments have dominated the conversation: Mounjaro (tirzepatide) and Wegovy (semaglutide). Both are MHRA-approved, weekly injectable pens designed to help adults struggling with obesity or weight-related health conditions find long-term success. But while they might seem similar on the surface, they … Continue reading Mounjaro vs. Wegovy: Which Weekly Weight Loss Injection is Right for You?